Helicobacter pylori infection and tumour necrosis factor-alpha increase gastrin release from human gastric antral fragments

Eur J Gastroenterol Hepatol. 1997 Aug;9(8):773-7. doi: 10.1097/00042737-199708000-00007.

Abstract

Objectives: To investigate the mechanism of the hypergastrinaemia associated with Helicobacter pylori infection by examining the effect of H. pylori infection and the cytokine tumour necrosis factor-alpha (TNF-alpha) on gastrin release from human antral fragments.

Design: In-vitro experimental study.

Methods: Human antral biopsy fragments were cultured for 6 h with and without TNF-alpha (20 ng/ml) and the gastrin released over the following 2-h stimulation period measured by radioimmunoassay. The integrity of the paracrine feedback loop inhibiting gastrin release was tested by concurrent administration of cholecystokinin (CCK).

Results: H. pylori-positive fragments were associated with significantly greater bombesin-stimulated gastrin release (increased by 40%, P < 0.05) and less inhibition produced by CCK administration (decreased by 55%, P < 0.05), than H. pylori-negative fragments. TNF-alpha treatment of H. pylori-negative fragments significantly enhanced bombesin-stimulated gastrin release (by 82%, P < 0.01) and diminished inhibitory feedback by CCK (by 53%, P < 0.05).

Conclusion: H. pylori infection is associated with enhanced gastrin release from human antrum and TNF-alpha produces a similar effect. Proinflammatory cytokines generated in the antrum in response to the infection are likely to play a significant role in the hypergastrinaemia of H. pylori infection.

MeSH terms

  • Bombesin / pharmacology
  • Cholecystokinin / pharmacology
  • Gastric Mucosa / chemistry
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / metabolism*
  • Gastrins / analysis
  • Gastrins / metabolism*
  • Helicobacter Infections / physiopathology*
  • Helicobacter pylori*
  • Humans
  • In Vitro Techniques
  • Pyloric Antrum / chemistry
  • Pyloric Antrum / drug effects
  • Pyloric Antrum / metabolism
  • Radioimmunoassay
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Gastrins
  • Tumor Necrosis Factor-alpha
  • Cholecystokinin
  • Bombesin